Supportive Care for Cognitively Impaired Patients and Families
Primary Purpose
Dementia
Status
Active
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
nurse-led supportive care assessment
Sponsored by
About this trial
This is an interventional supportive care trial for Dementia focused on measuring palliative, supportive, MCI
Eligibility Criteria
Inclusion Criteria:
- All patients enrolled in our alzheimers disease research center.
- All caregivers enrolled in our alzheimers disease research center.
Exclusion Criteria:
- not a community dweller at the time of entry into the study;
- have severe dementia and are incapable of responding to the outcome measures at baseline. 3. Participants who live alone and don't have a proxy will be excluded only if they are deemed as lacking capacity to provide informed consent at the time of entry into the study.
Sites / Locations
- VJ Periyakoil
Arms of the Study
Arm 1
Arm 2
Arm Type
Other
Experimental
Arm Label
Usual care
intervention arm
Arm Description
one random half of patients will receive usual care
one random half of patients will receive enhanced usual care (usual care plus nurse-led supportive care intervention)
Outcomes
Primary Outcome Measures
To identify the number of participants who express supportive care needs in both arms.
Only the participants randomized to the intervention arm will receive the nurse-led supportive care intervention (one session per month over a twelve-month period).
We hypothesize that compared to the control arm, many more patients in the intervention arm will express supportive needs and have them fulfilled by the study nurses.
Completion and documentation of advance directives (AD) and the Physicians Orders for Life Sustaining Treatment (POLST) in the electronic health records.
In both arms the investigators will track the completion, signage and documentation of advance directives and the POLST. AD has to be signed by the patient or proxy and witnessed by two qualifying witnesses. The POLST has to be signed by the patient/proxy and the patient's doctor. Both forms have to be uploaded into the electronic health records.
Change in Zarit Caregiver Burden scores over time:
The Zarit Burden Interview contains 22 items. Each item on the interview is a statement which the caregiver is asked to endorse using a 5-point scale. Response options range from 0 (Never) to 4 (Nearly Always) . The factor structure is a two-factor model, addressing personal strain and role strain. The investigators will assess change in Zarit scores between three points in time : on study entry, one year later and two year later.
Secondary Outcome Measures
Differences in Edmonton Symptoms Assessment Scale (ESAS) scores
The ESAS is designed to assist in the assessment of nine symptoms common in patients: pain, tiredness, nausea, depression, anxiety, drowsiness, appetite, wellbeing and shortness of breath, (there is also a line labelled "Other Problem"). The severity at the time of assessment of each symptom is rated from 0 to 10 on a numerical scale, 0 meaning that the symptom is absent and 10 that it is of the worst possible severity. The investigators will assess change in ESAS score of all participants at baseline, months 4, 12 and 18. The investigators hypothesize that patients with cognitive impairment will have higher scores than those with normal cognition. The investigators will also determine changes in the ESAS score (if any) over time.
Change in Patient Activation Measure over time
3-item survey that assesses a person's underlying knowledge, skills and confidence integral to managing his or her own health and healthcare.
PAM segments individuals into one of four activation levels along an empirically derived 100-point scale. Each level provides insight into an extensive array of health-related characteristics, including attitudes, motivators, and behaviors. Individuals in the lowest activation level do not yet understand the importance of their role in managing their own health, and have significant knowledge gaps and limited self-management skills. Individuals in the highest activation level are proactive with their health, have developed strong self-management skills, and are resilient in times of stress or change. PAM measures patient activation and agency: The investigators will assess changes in activation scores in ESAS scores between three points in time : on study entry, one year later and two year later.
Full Information
NCT ID
NCT03881579
First Posted
October 8, 2018
Last Updated
October 13, 2023
Sponsor
Stanford University
Collaborators
National Institute on Aging (NIA)
1. Study Identification
Unique Protocol Identification Number
NCT03881579
Brief Title
Supportive Care for Cognitively Impaired Patients and Families
Official Title
Supportive Care for Cognitively Impaired Patients and Families
Study Type
Interventional
2. Study Status
Record Verification Date
October 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
December 18, 2019 (Actual)
Primary Completion Date
December 31, 2024 (Anticipated)
Study Completion Date
December 31, 2025 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Stanford University
Collaborators
National Institute on Aging (NIA)
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Currently almost 5 million Americans suffer from the distressing symptoms related to dementia and this number that will triple by 2050. The overall goals of the proposed project are to evaluate, in community dwelling Alzheimer's Disease Research Center participants the benefits of a 12-month nurse-led early palliative intervention on symptoms, quality of life, health care resource use. The relevance of this research to public health is that there is an urgent need to improve the palliative care of persons with dementia living in the community. This study will contribute substantially to that effort.
Detailed Description
200 ADRC participants will be recruited and randomized 100 each to usual care (UC) or {usual care plus an early palliative care intervention} (EPC) to be delivered by a nurse over a twelve-month period. The EPC will include one nurse-led palliative consult for a two-hour virtual session followed by 11 monthly 30-minute phone/video sessions plus usual care. The study aims are to determine whether EPC will lead to (a) eliciting and alleviating the supportive care needs of patients, (b) help them complete and sign (with witnesses) their Advance Directives and the POLST (signed by the patient/proxy and their doctor) upload these into the electronic health records. Exploratory outcomes will include health resource use (e.g. hospital admissions and days, emergency visits) for the participants and caregiver burden for their caregivers. Mixed-methods framework will be utilized to analyze the audiotapes of the encounters between the research nurse and the patient during the twelve intervention sessions and to assess whether the information that is provided to participants differs by patient ethnicity and cognitive levels.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Dementia
Keywords
palliative, supportive, MCI
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
patients will be randomized to one of two groups:
1. (usual care) or (2). enhanced usual care i.e. usual care plus supportive care provided by a trained and supervised nurse
Masking
Outcomes Assessor
Masking Description
Outcomes will be assessed by blinded research associates
Allocation
Randomized
Enrollment
200 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Usual care
Arm Type
Other
Arm Description
one random half of patients will receive usual care
Arm Title
intervention arm
Arm Type
Experimental
Arm Description
one random half of patients will receive enhanced usual care (usual care plus nurse-led supportive care intervention)
Intervention Type
Behavioral
Intervention Name(s)
nurse-led supportive care assessment
Intervention Description
Trained project nurses will conduct systematic assessment and provide coaching to patients in the experimental arm
Primary Outcome Measure Information:
Title
To identify the number of participants who express supportive care needs in both arms.
Description
Only the participants randomized to the intervention arm will receive the nurse-led supportive care intervention (one session per month over a twelve-month period).
We hypothesize that compared to the control arm, many more patients in the intervention arm will express supportive needs and have them fulfilled by the study nurses.
Time Frame
Day 0, 4 months, one year
Title
Completion and documentation of advance directives (AD) and the Physicians Orders for Life Sustaining Treatment (POLST) in the electronic health records.
Description
In both arms the investigators will track the completion, signage and documentation of advance directives and the POLST. AD has to be signed by the patient or proxy and witnessed by two qualifying witnesses. The POLST has to be signed by the patient/proxy and the patient's doctor. Both forms have to be uploaded into the electronic health records.
Time Frame
Day 0, 4 months, one year, 18 months
Title
Change in Zarit Caregiver Burden scores over time:
Description
The Zarit Burden Interview contains 22 items. Each item on the interview is a statement which the caregiver is asked to endorse using a 5-point scale. Response options range from 0 (Never) to 4 (Nearly Always) . The factor structure is a two-factor model, addressing personal strain and role strain. The investigators will assess change in Zarit scores between three points in time : on study entry, one year later and two year later.
Time Frame
Day 0, 4 months, one year, 18 months
Secondary Outcome Measure Information:
Title
Differences in Edmonton Symptoms Assessment Scale (ESAS) scores
Description
The ESAS is designed to assist in the assessment of nine symptoms common in patients: pain, tiredness, nausea, depression, anxiety, drowsiness, appetite, wellbeing and shortness of breath, (there is also a line labelled "Other Problem"). The severity at the time of assessment of each symptom is rated from 0 to 10 on a numerical scale, 0 meaning that the symptom is absent and 10 that it is of the worst possible severity. The investigators will assess change in ESAS score of all participants at baseline, months 4, 12 and 18. The investigators hypothesize that patients with cognitive impairment will have higher scores than those with normal cognition. The investigators will also determine changes in the ESAS score (if any) over time.
Time Frame
Day 0, 4 months, one year, 18 months
Title
Change in Patient Activation Measure over time
Description
3-item survey that assesses a person's underlying knowledge, skills and confidence integral to managing his or her own health and healthcare.
PAM segments individuals into one of four activation levels along an empirically derived 100-point scale. Each level provides insight into an extensive array of health-related characteristics, including attitudes, motivators, and behaviors. Individuals in the lowest activation level do not yet understand the importance of their role in managing their own health, and have significant knowledge gaps and limited self-management skills. Individuals in the highest activation level are proactive with their health, have developed strong self-management skills, and are resilient in times of stress or change. PAM measures patient activation and agency: The investigators will assess changes in activation scores in ESAS scores between three points in time : on study entry, one year later and two year later.
Time Frame
one year, two years
10. Eligibility
Sex
All
Minimum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
All patients enrolled in the Stanford Alzheimers Disease Research Center (SADRC).
All caregivers enrolled in the Stanford Alzheimers Disease Research Center (SADRC).
Exclusion Criteria:
Institutionalized (not a community dweller) at the time of entry into the study;
Have severe dementia and are incapable of responding to the outcome measures at baseline. 3. Participants who live alone and don't have a proxy will be excluded only if they are deemed as lacking the capacity to provide informed consent at the time of entry into the study.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
VJ Periyakoil, MD
Organizational Affiliation
Stanford University
Official's Role
Principal Investigator
Facility Information:
Facility Name
VJ Periyakoil
City
Palo Alto
State/Province
California
ZIP/Postal Code
94304
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
Yes
IPD Sharing Plan Description
this will depend on if patients consent or not for release of data
IPD Sharing Time Frame
after study completion
IPD Sharing Access Criteria
by emailing study team
Learn more about this trial
Supportive Care for Cognitively Impaired Patients and Families
We'll reach out to this number within 24 hrs